Oxidative stress correction in the treatment of severe keratoconjunctivitis sicca in patients with Sjorgen’s syndrome

Close metadata

Recommended articles:

The place of ciclosporin A cationic emulsion 0.1% in the therapy of xerophthalmia. Russian Annals of Ophthalmology. 2024;(2):102-111

Three-component tear substitute as preoperative support in glaucoma surgery. Russian Annals of Ophthalmology. 2024;(3):51-58

Peculiarities of the metabolic profile of blood serum and follicular fluid with a «poor» ovarian response in IVF-programs. Russian Journal of Human Reproduction. 2023;(6):49-56

Treatment of oxidative stress and male reproductive rehabilitation. Russian Journal of Human Reproduction. 2023;(6):106-115

Efficacy of Mexidol in combination with cerebral revascularization in the treatment of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):67-74

Oxidative stress prevention as an effective preventive strategy in type 2 diabetes mellitus. Russian Journal of Preventive Medicine. 2024;(3):117-123

Cognitive impairment in post-traumatic stress disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):69-74

Therapeutic and preventive effect of alpha-glutamyl-tryptophan on gastric mucosal lesions caused by non-steroidal anti-inflammatory drugs. An experimental study. Russian Journal of Evidence-Based Gastroenterology. 2024;(2):25-34

Possibilities of using cytoprotectors in complex therapy of chronic coronary heart disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(4):410-419

Determination of indications for antioxidant therapy at the stage of pregravidar preparation of patients with early fetal loss in anamnesis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):66-70

Purpose — to evaluate the antioxidative effect of artificial tears in the treatment of keratoconjunctivitis sicca (KCS). Material and methods. The study included 43 patients (60 eyes) with severe KCS: 38 women (50 eyes) and 5 men (10 eyes) aged from 27 to 76 years (in average 52 years). Patients were randomly divided into 2 groups; all patients used therapeutic silicone hydrogel soft contact lens (SCL) and instillations of 0.05% Cyclosporin A (CyA) 2 times a day. Patients of the first group (22 people, 30 eyes) used 0.15% hyaluronic acid. In the second group, patients (21 people, 30 eyes) used a tear substitute with similar surface-active component, but with antioxidant properties. The results of the treatment were evaluated using basic and additional research methods at 1, 3, 6 and 12 months. Results. Corneal epithelialization was achieved after 1 month of conservative treatment in all patients who wore SCLs and were treated with instillations of 0.05% CyA and artificial tears. Then the lenses were removed and the patients were switched to instillations of CyA and artificial tears. Comparative analysis of the results showed that higher functional indicators were achieved in the second group, where patients used Artelac Rebalance drops with antioxidant properties. Conclusion. Improvement of clinical and functional parameters in the treatment of severe forms of KCS was achieved by direct action on both links of pathogenesis with minimal amounts of the drugs and the frequency of their use. Subsequent supportive therapy contributed to stabilization of the results and further increase of the functional parameters.

Keywords:

keratoconjunctivitis sicca

Cyclosporin A

tear substitutes

oxidative stress

Authors:

Safonova T.N.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Gladkova O.V.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

Boev V.I.

Research Institute of Eye Diseases, 11 A, B, Rossolimo St., Moscow, Russian Federation, 119021

List of references:

Safonova TN, Vasil’ev VI, Lihvanceva VG. Sindrom Shegrena. Rukovodstv odlya vrachej. M.: Izdatel’stvo moskovskogo universiteta; 2013. (In Russ.)
Zoukhri D. Effect of inflammation on lacrimal glandfunction. Exp Eye Res. 2006;82(5):885-898. https://doi.org/10.1016/j.exer.2005.10.018
Chighizola CB, Ong VH, Meroni PL. The Use of Cyclosporine A in Rheumatology: Comprehensive Review. Clinical Reviews in Allergy and Immunology. 2016;52:401-423. https://doi.org/10.1007/s12016-016-8582-3
Devecı H, Kobak S. The efficacy of topical 0.05% cyclosporine A in patients with dry eye disease associated with Sjögren’s syndrome. Int Ophthalmol. 2014;3:32-39. https://doi.org/10.1007/s10792-014-9901-4
Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol. 2009;54(3):32-138. https://doi.org/10.1016/j.survophthal.2009.02.002
Turrents JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep. 1997;17:3-8. https://doi.org/10.1007/978-1-4614-3573-0_6
Perricone C, De Carolis C, Perricone R. Glutathione: a key player in autoimmunity. Autoimmunity Rev. 2000;8:697-701. https://doi.org/10.1016/j.autrev.2009.02.020
Hongiun Du, Xu Xiao, Travis Stiles, et al. Novel Mechanistic Interplay between Products of Oxidative Stress and Components of the Complement System in AMD Pathogenesis. Open J Ophthalmol. 2016;6(1):43-50. https://doi.org/10.4236/ojoph.2016.61006
Kruk J, Kubasik-Kladna K, Aboul-Enein HY. The role oxidative stress in the pathogenesis of eye diseases: current status and a dual role of physical activity. Mini Rev Med Chem. 2015;16(3):241-257. https://doi.org/10.2174/1389557516666151120114605
Hao Liu, Minie Sheng, Yu Liu, et al. Expression of SIRT1 and oxidative stress in diabetic dry eye. Int J Clin Exp Pathol. 2015;8(6):7644-7653. https://doi.org/10.3724/sp.j.1008.2012.00621
Yuichi Uchino, Tetsuya Kawakita, Masaki Miyazawa, et al. Oxidative Stress Induced Inflammation Initiates Functional Decline of Tear Production. PLoS One. 2012;7(10):45-48. https://doi.org/10.1371/journal.pone.0045805
Pagano G, Gastello G, Pallardo F.V. Sjögren´s syndrome-associated oxidative stress and mitochondrial dysfunction: Prospects for chemoprevetion trials. Free Radical Research. 2013;47(3):71-73. https://doi.org/10.3109/10715762.2012.748904
Wakamatsu TH, Dogru M, Matsumoto Y, et al. Evaluation of lipid oxidative stress status in Sjögren syndrome patients. Invest Ophthalmol Vis Sci. 2013;54(1):201-210. https://doi.org/10.1167/iovs.12-10325
Macri A, Scanarotti C, Bassi AM, et al. Evaluation of oxidative stres levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15% and vitamin B12 eye drops. Graefes Arch Clin Exp Ophthalmol. 2015;253:425-430. https://doi.org/10.1007/s00417-014-2853-6
Deng R, Hua X, Li J, et al. Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS One. 2015;10:1-16. https://doi.org/10.1371/journal.pone.0126561
Yanwei LI, Haifeng Liu, Wei Zeng, Jing Wei. Edaravone protects against hyperosmolarity-induced oxidative stress and apoptosis in primary human corneal epithelial cells. PLoS One. 2017;12(3):17-20. https://doi.org/10.1371/journal.pone.0174437
Clouzeau C, Godefroy D, Riancho L, et al. Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro. Mol Vis. 2012;18:851-863. https://doi.org/10.1016/j.toxlet.2011.05.546
Choi W, Lian C, Ying L, et al. Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease. Curr Eye Res. 2016;41(9):1143-1149. https://doi.org/10.3109/02713683.2015.1098707
Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31(3):271-285. https://doi.org/10.1016/j.preteyeres.2012.02.003
Romano MR, Biagioni F, Carrizzo A, et al. Effects of vitamin B12 on the corneal nerve regeneration in rats. Exp Eye Res. 2014;120:109-117. https://doi.org/10.1016/j.exer.2014.01.017
AL-Maskari M WMI, Ali A, et al. Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes. Nutrition. 2012;28:7-8. https://doi.org/10.1016/j.nut.2012.01.005
Nezzar H, Mbekeani JN, Noblanc A, et al. Investigation of antioxidant systems in human meibomian gland and conjunctival tissues. Exp Eye Res. 2017;165:99-104. https://doi.org/10.1016/j.exer.2017.09.005

Close metadata